Psycho-social Consequences of Systemic Lupus Erythematosus
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03913754 |
|
Recruitment Status :
Recruiting
First Posted : April 12, 2019
Last Update Posted : August 20, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Lupus Erythematosus | Other: Psycho-social consequences of lupus erythematosus |
Systemic lupus erythematosus (SLE) is a rare chronic autoimmune disease (1/2000 inhabitants) that evolves in periods of recurrent remissions. Sufferers are most often young women of childbearing age. SLE affects the life of a couple like family life (financial, emotional, relational or sexual conditions of the couple). In addition, the disease and its treatments can hinder the possibility of building a family project (pregnancy).
The purpose of the Psy-LUP study is to study the impact of SLE on the social participation of patients, that is to say on their ability to get involved in different areas of daily life. These repercussions could be all the more important as lupus disease is active and complicated by severe diseases such as kidney disease. We want to study how sick people and their loved ones (spouse in particular) think about lupus disease, how it fits into their life history, how people have adapted to this disease, and how it affects their lives. could have on their social participation, their social support, their life of couple. The Psy-LUP study will be carried out in different care services, and by telephone interviews at home, with two main axes: (1) a study by questionnaire with patients (n = 100); (2) a qualitative study through research interviews with patients (n = 40) and their spouses (n = 20). The realization of this project will allow us to evaluate and understand the impact of SLE on the life of the couple and its relational and affective components. In addition, the Psy-LUP study will describe the representations that sick people and their relatives have of lupus disease. All the data collected will make it possible to target interventions with 1) patients and their relatives, in terms of therapeutic education, psychosocial support, support groups (associations); 2) caregivers caring for people with SLE, so that they can integrate the issues of the patient's experience in their care practice and their reflection on therapeutic strategies.
| Study Type : | Observational [Patient Registry] |
| Estimated Enrollment : | 160 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 1 Day |
| Official Title: | Psychosocial Consequences of Systemic Lupus Erythematosus: a Study of Patients and Their Spouses Psy-LUP Study |
| Actual Study Start Date : | June 30, 2019 |
| Estimated Primary Completion Date : | July 1, 2020 |
| Estimated Study Completion Date : | July 1, 2021 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Lupus Patients with kidneys failure
Assessment of quality of life on everydays life trough questionnare
|
Other: Psycho-social consequences of lupus erythematosus
It will be necessary to take into account the psychosocial experience of the disease [47] and to allow a narrative exploration of this experience and its psycho-social consequences both for the patients and their spouses (ie the experiential dimension of the disease in connection with the life trajectory, the life of a couple, elaborate representations concerning the disease). The purpose of this approach is not only to question the meaning of the disease (beliefs, representations), the psycho-social management of the disease, its inclusion in the socio-cultural condition of the patients, but also to allow an analysis of the inscription. of the disease in the relationship and its implications (relational, affective, sexual) and its impact on the possibilities of social participation. |
|
Lupus Patients without kidneys failure
Assessment of quality of life on everydays life trough questionnare
|
Other: Psycho-social consequences of lupus erythematosus
It will be necessary to take into account the psychosocial experience of the disease [47] and to allow a narrative exploration of this experience and its psycho-social consequences both for the patients and their spouses (ie the experiential dimension of the disease in connection with the life trajectory, the life of a couple, elaborate representations concerning the disease). The purpose of this approach is not only to question the meaning of the disease (beliefs, representations), the psycho-social management of the disease, its inclusion in the socio-cultural condition of the patients, but also to allow an analysis of the inscription. of the disease in the relationship and its implications (relational, affective, sexual) and its impact on the possibilities of social participation. |
- the physical, psychological and social impact of chronic diseases [ Time Frame: 12 months ]Quality of life scale Short Study Form-36 (SF-36)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Age> 18 years
- Presenting an LES according to ACR or SLICC criteria
- Being followed in Marseille in Nephrology or Internal Medicine as part of the Competence Center Lupus PACA
- Having agreed to participate in the study after information
Exclusion Criteria:
- Minor person
- Person deprived of liberty
- Person not affiliated to a social security scheme
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03913754
| Contact: Noémie Jourde Chiche | 04 91 38 41 38 | Noemie.JOURDE@ap-hm.fr | |
| Contact: Patrick Sudour | 04 91 38 29 03 | promotion.interne@ap-hm.fr |
| France | |
| Assitance Publique Hôpitaux de Marseille | Recruiting |
| Marseille, France, 13000 | |
| Contact: Noemie Jourde-Chiche, MD/PhD noemie.jourde@ap-hm.fr | |
| Responsible Party: | Assistance Publique Hopitaux De Marseille |
| ClinicalTrials.gov Identifier: | NCT03913754 History of Changes |
| Other Study ID Numbers: |
2018-29 |
| First Posted: | April 12, 2019 Key Record Dates |
| Last Update Posted: | August 20, 2019 |
| Last Verified: | April 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Lupus Erythematosus, Systemic Connective Tissue Diseases Autoimmune Diseases Immune System Diseases |